BackAssembly Biosciences Overview
Assembly Biosciences Inc

Assembly Biosciences Target Price

See Assembly Biosciences's analyst price targets ($45) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.95

Average Target Price

$45.0050.3% upside

1 analysts in the last 4 months

High: $45 | Low: $45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-15Mizuho Securities$4550.3% upsideOpen
2025-11-20Mizuho SecuritiesSalim Syed$4033.6% upsideOpen
2025-09-24JMP SecuritiesRoy Buchanan$3826.9% upsideOpen
2024-09-24Mizuho SecuritiesSalim Syed$3620.2% upsideOpen
2024-09-20JefferiesDennis Ding$3516.9% upsideOpen

Assembly Biosciences (ASMB) FAQ

Assembly Biosciences (ASMB) currently reports a target price of $45. Use the charts on this page to explore Assembly Biosciences's target price history and peer comparisons.

Analysts' average 12-month price target for Assembly Biosciences is $45, about 50.3% upside from the current share price of $29.95. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $45, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Assembly Biosciences, and consider following ASMB for alerts when major investors trade the stock.

Assembly Biosciences is classified in the Healthcare sector. On target price, it currently shows $45. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASMB with unrelated industries.